Free Trial

Elanco Animal Health (ELAN) Earnings Date, Estimates & Call Transcripts

Elanco Animal Health logo
$13.36 -0.04 (-0.30%)
(As of 11/22/2024 ET)

Elanco Animal Health Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 24Estimated
Actual EPS
(Nov. 7)
$0.13 Beat By $0.01
Consensus EPS
(Nov. 7)
$0.12

Elanco Animal Health posted Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.13, which topped the consensus estimate of $0.12 by $0.01. Quarterly revenue fell 3.6% year-over-year to $1.03 billion, below the consensus estimate of $1.04 billion. With a trailing EPS of $0.40 and a P/E Ratio of 33.40, Elanco Animal Health's earnings are expected to grow 1.10% next year, from $0.91 to $0.92 per share.

ELAN Upcoming Earnings

Elanco Animal Health's next earnings date is estimated for Monday, February 24, 2025, based off prior year's reporting schedules.

Get Elanco Animal Health Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Elanco Animal Health and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ELAN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ELAN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Elanco Animal Health Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.26$0.26$0.260.250 - 0.280
Q2 20241$0.24$0.24$0.240.230 - 0.260
Q3 20241$0.11$0.11$0.110.090 - 0.140
Q4 20241$0.18$0.18$0.180.130 - 0.180
FY 20244$0.79$0.79$0.79 
Q1 20251$0.32$0.32$0.32 
Q2 20251$0.32$0.32$0.32 
Q3 20251$0.14$0.14$0.14 
Q4 20251$0.18$0.18$0.18 
FY 20254$0.96$0.96$0.96 
Q1 20261$0.36$0.36$0.36 
Q2 20261$0.32$0.32$0.32 
Q3 20261$0.17$0.17$0.17 

Elanco Animal Health Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/24/2025
(Estimated)
------- 
11/7/2024Q3 2024$0.12$0.13+$0.01-$0.47$1.04B$1.03B          
8/8/2024Q2 2024$0.24$0.30+$0.06$0.70$1.15B$1.18B      
5/8/2024Q1 2024$0.26$0.34+$0.08$0.62$1.18B$1.21B    
2/26/2024Q4 2023$0.10$0.08 -$0.02$0.45$1.00B$1.04B      
11/7/2023Q3 2023$0.12$0.18+$0.06$2.58$1.04B$1.07B      
8/7/2023Q2 2023$0.05$0.18+$0.13$0.56$1.04B$1.06B    
5/9/2023Q1 2023$0.29$0.45+$0.16$0.69$1.18B$1.26B      
2/21/2023Q4 2022$0.13$0.19+$0.06$0.49$980.94M$988.00M    

Elanco Animal Health Earnings - Frequently Asked Questions

Elanco Animal Health has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates. Learn more on ELAN's earnings history.

Elanco Animal Health updated its fourth quarter earnings guidance on Thursday, November, 7th. The company provided EPS guidance of $0.13-$0.18 for the period, compared to the consensus EPS estimate of $0.16. The company issued revenue guidance of $1.00-$1.03 billion, compared to the consensus revenue estimate of $1.01 billion.

In the previous quarter, Elanco Animal Health (NYSE:ELAN) reported $0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $0.12 by $0.01. Learn more on analysts' earnings estimate vs. ELAN's actual earnings.

The conference call for Elanco Animal Health's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Elanco Animal Health's latest earnings report can be read online.
Read Transcript

Elanco Animal Health's earnings report can be found in their filing with the SEC.
View SEC filing

Elanco Animal Health (NYSE:ELAN) has a recorded annual revenue of $4.42 billion.

Elanco Animal Health (NYSE:ELAN) has a recorded net income of -$1.23 billion. ELAN has generated $0.40 earnings per share over the last four quarters.

Elanco Animal Health (NYSE:ELAN) has a trailing price-to-earnings ratio of 33.40 and a forward price-to-earnings ratio of 14.68. The price/earnings-to-growth ratio is 1.4.

Elanco Animal Health's earnings are expected to grow from $0.91 per share to $0.92 per share in the next year, which is a 1.10% increase.

`

More Earnings Resources from MarketBeat



This page (NYSE:ELAN) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners